Have a personal or library account? Click to login
The role of eNOS and AGT gene polymorphisms in secondary pulmonary arterial hypertension in Romanian children with congenital heart disease  Cover

The role of eNOS and AGT gene polymorphisms in secondary pulmonary arterial hypertension in Romanian children with congenital heart disease

Open Access
|Sep 2013

References

  1. 1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001; 357(3):593-615.10.1042/bj3570593
  2. 2. Rosas-Vargas H, Coral-Vazquez RM, Tapia R, Borja JL, Salas RA, Salamanca F. Glu298Asp Endothelial Nitric Oxide Synthase Polymorphism Is a Risk Factor for Erectile Dysfunction in the Mexican Mestizo Population. J Androl. 2004; 25(5):728-732.10.1002/j.1939-4640.2004.tb02847.x
  3. 3. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet. 1997; 51(1):26-30.10.1111/j.1399-0004.1997.tb02409.x
  4. 4. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med. 1996; 2(1):41-45.10.1038/nm0196-41
  5. 5. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary disease in the UK. Circulation. 1999; 100 (14):1515-1520.10.1161/01.CIR.100.14.1515
  6. 6. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998; 103(1):65-69.10.1007/s004390050785
  7. 7. Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, et al Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Comm. 2001; 284(2):426-430.10.1006/bbrc.2001.5007
  8. 8. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci. 2000; 66(26):2557-2562.10.1016/S0024-3205(00)00589-0
  9. 9. Budts W, Pokreisz P, Nong Z, Van Pelt N, Gillijns H, GerardR, et al. Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation. 2000; 102(23):2880-2885.10.1161/01.CIR.102.23.288011104748
  10. 10. Sarkar R, Meinberg EG, Stanley JC, Goron D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 1996; 78(2):225-230.
  11. 11. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989; 83(5):1774-1777.10.1172/JCI1140813038902540223
  12. 12. Say YH, Ling KH, Duraisamy G, Isaac S, Rosli R. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: A case control study. BMC Cardiovascular Disorders. 2005; 5:7.10.1186/1471-2261-5-7109056415811183
  13. 13. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, et al Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens. 1997; 15(6):607-611.10.1097/00004872-199715060-000069218179
  14. 14. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, et al Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 1994; 8:521-524.
  15. 15. Morise T, Takeuchi Y, Takeda R. Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. Journal of Internal Medicine. 1995; 237(2):175-180.10.1111/j.1365-2796.1995.tb01158.x7852920
  16. 16. Colomba D, Duro G, Corrao S, Argano C, Di Chiara T, Nuzzo D et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. Immun Ageing. 2008; 5:4.10.1186/1742-4933-5-4243054118510731
  17. 17. Fatini C, Mannini L, Sticchi E, Cecchi E, Bruschettini A, Leprini E et al. eNOS gene affects red cell deformability: role of T-786C, G894T, and 4a/4b polymorphisms. Clin Appl Thromb Hemost. 2005; 11(4):481-488.10.1177/10760296050110041716244776
  18. 18. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235- Thr allele of the human angiotensinogen gene. Hum Mol Genet. 1993; 2(5):609-610.10.1093/hmg/2.5.6098518804
  19. 19. Sun LR, Wang C, Wu AQ, Yan BM, Li DM, Zhang JL, et al. Gene polymorphism of the endothelial nitric oxide synthase enzyme and pulmonary hypertension in patient with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi, 2008; 31(5):335-340.
  20. 20. Men C, Tang K, Lin G, Li J, Zhan Y. ENOS-G894T polymorphism is a risk factor for essential hypertension in China. Indian J Biochem Biophys. 2011; 48(3):154-157.
  21. 21. Ulrich S, Hersberger M, Fischler M, Nussbaumer- Ochsner Y, Treder U, Russi EW. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease. Respiration. 2010; 79(4):288-295.10.1159/00022624319556740
  22. 22. Yildiz P, Oflaz H, Cine N, Erginel-Unaltuna N, Erzengin F, Yilmaz V. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD. Respir Med. 2003; 97(12):1282-1288.10.1016/j.rmed.2003.06.00114682408
  23. 23. Li R, Lyn D, Lapu-Bula R, Oduwole A, Igho-Pemu P, Lankford B. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function and blood pressure in African Americans. Am J Hypertens. 2004; 17(7):560-567.10.1016/j.amjhyper.2004.02.01315233974
  24. 24. Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J. 2004; 147(3):516-521.10.1016/j.ahj.2003.10.03214999203
  25. 25. Salimi S., Fioozrai M, Nourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res. 2006; 124:683-688.
  26. 26. Safarinejad MR, Shafiei N, Safarinejad S. The role of endothelial nitric oxide synthase (eNOS) T-786C, G894T, and 4a/b gene polymorphisms in the risk of idiopathic male infertility. Mol Reprod Dev. 2010; 77(8):720-727.10.1002/mrd.2121020586099
  27. 27. Patkar S, Charita BH, Ramesh C, Padma T. High risk of essential hypertension in males with intron 4 VNTR polymorphism of eNOS gene. Indian Journal of Human Genetics. 2009; 15(2):49-53.10.4103/0971-6866.55215291094820680151
  28. 28. Champion HC, Bivalacqua TJ, Greenberg SS, Giles TD, Hyman AL, Kadowitz PJ. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient micePNAS. Proc. Natl. Acad. Sci USA, 2002; 99(20): 13248-13253.10.1073/pnas.18222589913061912237402
  29. 29. Delcroix M, Dorfmuller P, MacLean MR, Barbera JA, Hoeper MM, Ghofranif H, et al. Pulmonary hypertension: future therapies. European respiratory Monograph. 2003; 27:84-109.
  30. 30. Mehta S, Stewart DJ, Langleben D, Levy RD. Shortterm pulmonary vasodilation with l-arginine in pulmonary hypertension. Circulation. 1995; 92(6):1539-1545.10.1161/01.CIR.92.6.1539
  31. 31. Solari V, Puri P. Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension. J Pediatr Surg. 2004; 39(3):302-306.10.1016/j.jpedsurg.2003.11.00815017542
  32. 32. Gatti RR, Santos PS, Sena AA, Marangoni K, Araújo MA, Goulart LR. The interaction of AGT and NOS3 gene polymorphisms with conventional risk factors increases predisposition to hypertension. J Renin Angiotensin Aldosterone Syst. 2012 Jul 12. (Epub ahead of print)10.1177/147032031245202722791701
  33. 33. Meroufel DN, Médiène-Benchekor S, Dumont J, Benhamamouch S, Amouyel P, Brousseau T. A study on the polymorphisms of the renin-angiotensin system pathway genes for their effect on blood pressure levels in males from Algeria. J Renin Angiotensin Aldosterone Syst. 2013 Apr 16. (Epub ahead of print) 10.1177/147032031348589823592589
DOI: https://doi.org/10.2478/rrlm-2013-0031 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 267 - 274
Published on: Sep 19, 2013
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Rodica Togănel, Iolanda Muntean, Carmen Duicu, Amalia Făgărăşan, Liliana Gozar, Claudia Bănescu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.

Volume 21 (2013): Issue 3 (September 2013)